JNJ vs CAH
By Alex · Tickerpine
Johnson & Johnson vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CAH |
|---|---|---|
| Price | $263.81 | $249.57 |
| Market cap | $635.07B | $57.79B |
| P/E ratio | 40.0 | 34.5 |
| ROE | 20.02% | — |
| Profit margin | 16.20% | 0.67% |
| Revenue growth | 5.90% | 5.80% |
| Dividend yield | 2.03% | 0.83% |
| Beta | 0.21 | 0.50 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CAH in plain English
- JNJ is the bigger company — about 11.0× the market cap of CAH.
- CAH is cheaper on earnings (P/E 34.5 vs 40.0).
- JNJ is growing revenue faster (6% vs 6%).
- JNJ has the higher dividend yield (2.03% vs 0.83%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.